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Summary.-The anti-inflammatory agent sodium aurothiomalate appears to act
upon mononuclear phagocytes, inhibiting their lysosomal enzyme activity. Evidence
is presented that gold salts can increase the number of lung tumour nodules that
develop following intravenous injection of tumour cells and pretreatment can enhance
the take of a subcutaneous tumour inoculum. In contrast, they do not affect the later
growth of tumour. Gold salts can also suppress the action of systemically ad-
ministered C. parvum in inhibiting the growth of subcutaneous tumours. These
results are taken as supporting the evidence in favour of a fast acting nonspecific
anti-tumour mechanism, probably macrophage mediated, that can be inhibited by
gold salts and enhanced by C. parvum. The effect of gold salts upon other biological
changes induced by C. parvum is examined, including its adjuvant action, and the
results are discussed in the context of the mechanisms underlying the immuno-
therapeutic action of this organism.
THE INJECTION of dead Corynebact- and immunosuppressive effects can be
erium parvum into animals inoculated obtained on both T dependent and T
with tumour cells has been found, under independent immune responses (Asherson
certain experimental conditions, to inhibit and Allwood, 1971; Scott, 1974c; Howard,
the growth or cause the regression of a Christie and Scott, 1973; Warr and
wide variety of isogeneic tumours (Wood- James, 1975). As with other adjuvants,
ruff and Boak, 1966; Halpern et al., the dose and timing of the injections are
1966; Milas et al., 1974; Scott, 1974a, crucial to the outcome. The mechanisms
b). Its effectiveness as an anti-tumour underlying these effects are still obscure,
agent in man is under investigation as indeed is their relation to each
(Israel and Halpern, 1972; Woodruff et other.
al., 1974a). There is abundant evidence that C.
A number of other biological effects parvum primarily influences the mono-
follow its injection; these may or may nuclear phagocyte system and because
not be part of the anti-tumour action. of the importance of macrophages in
There is, for example, widespread pro- defence against neoplastic disease (see
liferation, redistribution and mobilization Levy and Wheelock, 1974), we decided
of lymphoid cells including haemato- to inhibit. certain activities of these
poietic stem cells (Bennett and Cud- cells and to study the effect on tumour
kowicz, 1968; McBride, Jones and Weir, immunity and on the anti-tumour action
1974; Warr and Sljivic, 1974; Castro, of C. parvum. For this purpose we
1974). Mononuclear phagocytes are chose the anti-inflammatory agent sodium
markedly increased and become function- aurothiomalate because it is known to
ally more active in a variety of tests be concentrated within phagocytic cells
(Halpern et al., 1]964; Wilkinson et al., and to inhibit their lysosomal enzyme
1972; Ghaffar et al., 1974). Adjuvant activity (Persellin and Ziff, 1966).INHIBITION OF ANTI-TUMOUR ACTION OF C. PARVUM 559
MATERIALS AND METHODS heparin. Smears were stained by Leishman
or Gram stain.
Corynebacterium parvum.-C. parvum Blooddifferential count.-Monocytes, poly-
NCTC 10390 from the National Collection morphs and lymphocytes were distinguished
of Type Cultures, Colindale, London, was on Leishman and peroxidase stained smears.
grown, harvested and prepared as a formol The peroxidase stain was carried out accord-
killed suspension (see Dawes, Tuach and ing to the method of Kaplow (1965).
McBride, 1974). The organisms were washed
once in saline immediately before use to
decrease toxicity. Unless stated, mice were RESULTS
injected i.p. with 0 7 mg dry wt organisms
in 01 ml sterile saline. Subcutaneous tumour
Gold salts.-Mice received 1 or 5 mg The effect of gold salt on tumour
sodium aurothiomalate (Myocrisin, 45% me- growth.-When the multiple injection
tallic gold, May & Baker Ltd, Dagenham, schedule for gold salts was started 2 days
England) in 0-2 ml saline i.p. or i.v., either before 104 tumour cells, administered
as a single injection or 3 injections a week subcutaneously, the tumours were larger up to a total of8 (multiple injection schedule). throu hout thep er ervarger Mice receiving treatment showed no visible throughout the period of observation.
signs of distress at any time. The mean sum of the tumour diameters
Animals and tumour.-The mice were was 50 mm compared with 45 in the
adult (18-22 g body weight) CBAs. The controls (P < 0'01, 8 mice per group).
isogeneic methylcholanthrene induced fibro- If the series of gold salt injections was
sarcoma was in its 18th transplant genera- started 2 days after tumour inoculation
tion. Viable cell suspensions were prepared there was no effect. This suggests that
as described by Woodruff and Boak (1966) there is a stage at or soon after tumour
and were injected i.v. into the lateral tail inoculation that gold salt can alter, vein or s.c. into the hind thigh. The and that the result is an increase in the diameters of the s.c. tumours were measured ,,
3 times a week and the results expressed as number of cells that "take and go on
the mean of the tumour diameters of the to produce tumour.
group. The sum of individual tumour Inhibition of anti-tumour (s.c.) action
diameters over the period of observation of C. parvum.-In these experiments all
was taken (Woodruff, McBride and Dunbar, control groups which received gold salts
1974b) for statistical analyses by the non- after 104 tumour cells s.c. grew tumours
parametric Wilcoxon Rank-Sum test (Scien- at a very similar rate and to the same
tific Tables, Geigy, Basle, Switzerland). extent as those receiving tumour alone
The number of lung tumour nodules present and are omitted for the sake of clarity. 23 days after i.v. injection of tumour cells As expected (Woodruff and Dunbar was counted macroscopically. 1 C p Anti-sheep red blood cell response.-Mice 1973), C. parvum slowed the growth of
were injected with 1 X 108 washed SRBC. the tumour, particularly 2-3 weeks after
Haemagglutination titres of sera were mea- injection (Fig. la). Multiple injections
sured by the Microtitre technique (Cooke of gold salts significantly inhibited the
Engineering, Alexandria, Va). 25 pl volumes anti-tumour action ofC. parvum (P<0 01,
of serum dilutions, phosphate saline and Fig. la). In contrast, single injections
1% SRBC were incubated at 37°C for of 1 mg gold salts either before or after
30 min and 40C overnight before reading for injection of C. parvum were essentially
agglutination. * * l Antibodies to C. parvum.-Antibodies to tneffective see legend for details).
C. parvum were assayed by the agglutination To investigate whether prior or post-
test described by Woodruff et al. (1974b). treatment with gold salt was necessary
Collection and examination of peritoneal for inhibition of the action of C. parvum,
exudate calls (PEC).-These were collected another experiment using 5 mg rather
by lavage of the peritoneal cavity with than 1 mg of gold salt was set up (Fig.
minimal Eagle's medium and 10 i.u./ml ib). Prior treatment with gold almost
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Gold salts i.p.-Inhibition of cinti-tumour(s.c.)
Action of C.parvum-l 15 1
- A
Tumour 10- 7 .-/
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(mm) /
5-
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Fic. la.- Inhibitiov of the (ulati-tumour actiont of C. parvum by gold s8lts. All mice received 104 tumour
cells s.c. on Day 0. In addition, all except the control group (x ---- x ) received 0 7 mg C.
p(arvum i.p. on Day +3 FIG. la.-C. parvum alone (0 0) significantly (P < 001)
inihibited tumour growth. This effect could be prevented by giving multiple i.p. gold salt injections
starting on Day +2 (- *; P < 001 with C. parvum; 0 01 < P < 0-02 with control
group). Single i.p. injections of 1 mg gold salts given on Day + 2 (O- - - -Q) Day + 4
(E C) Gr Day +7 (A. A) were, by comparison, only marginally effective (P < 0-02,
P < 0 01, P < 0 05-with C,. pairvum group).
completely abolished the anti-tumour experiment was performed to find out
effect of C. parvunt. Post-treatment with if single injections of 1 mg gold salt
gold had no significant effect. had the same effect. Tumour metastases
were dramatically increased if gold was
given from 2 days before up to 3 days
Intravenous tumour after tumour (Table I, Expt 2).
The effect of gold salt on tumour meta- The effect ofgold salt on the anti-tumour
stases-.Repeated gold injections were (i.v.) action of C. parvum. As expected
started 2 days before tumour injection. (Milas et al., 1974) pre-treatment with C.
The number of tumour nodules found in parvum almost completely abolished the
the lung was significantly increased in development of tumour metastases in
mice receiving repeated gold salt injec- the lung (Table I, Expt 1). Multiple
tions starting 2 days before tumour injections of gold salts had no effect
injection (Table I, Expt 1). A further upon this action ofC. parvum.INHIBITION OF ANTI-TUMOUR ACTION OF C. PARVUM 561
Gold salts i.p.-Inhibition of Anti-Tumour( s.c.)
Action of C.parvum - 2
15I
Tumour ' 0 .
Diam T"r
(mm) 10-- i / " T
5]0
10 15 20 25
DAYS
FmG. lb- The experimental plan was identical to that in Fig. la except that single 5 mg i.p. injec-
tions of gold salts were given on Day +2, one day before C. parvumn (O- -O), or on Day
±+4 (I----El)- The former treatment was effective in inhibiting the action of C. parvumn
(not significantly different from control group, x----x), whereas the latter treatment was
less effective (not significantly different from C. parvum group, A A). Bars, where
shown, represent 1 s.e. (8 mree per group).
The effect of gold salt on adjuvant action (Aliner et al., 1974).
and antibody response Because of the lack of a comparable
Intramuscular gold salt injection has study, we examined the influence of
been reported not to affect the delayed gold salt upon the response of mice to
hypersensitivity response of guinea-pigs sheep red blood cells with the dosages
to iphhera txoi an diitrchlro and routes of administration used in
benzene, nor the antibody response O hssuy nve of yvlal ifra
rabbits to BSA, typhoid-paratyphoid tion on the action of gold salts, haem-
vaccine and Esch. coli (Persellin, Smiley glutination was chosen as an assay so
and Ziff, 1967). It increased the plaque that the timing of the responses could be
forming cell response of mice to sheep examined.
red blood cells (Scheiffarth, Baenkler and The immune response to sheep red
Pfister, 1971; Measel, 1975) but, given blood cells.-Mice received 108 SRBC
by the i.p. route, did not modify the either i.v. (Fig. 2a) or s.c. into the hind
antibody response to Semliki Forest virus thigh (Fig. 2b) on Day 0. C. parvum was562 W. H. McBRIDE, S. TUACH AND B. P. MARMION
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FIG. 2.-The effect of gold salt upon the immune response to s.c. and i.v. SRBC.-All mice received
108 SRBC s.c. (Fig. 2a) or i.v. (Fig. 2b) Day 0. Gold salt (x groups) or saline (0 groups) i.p.
injections were started Day -4. C. parvum ( x x; *- ---) was given i.p. Day -3.
Results are expressed as mean log2 haemagglutination titre A 1 s.e. Each group contained
6 mice.INHIBITION OF ANTI-TUMOUR ACTION OF C. PARVUM 563
TABLE I.-Increase in the Number of Lung Tumour Nodules in Mice Treated with Gold
Salt and the Effect of C. parvum
No. oftumour nodulesl
Protocol Median Range Pt
Expt 1
Tumour i.v. 6 4-23
- C. parvumn Tumouri.v. 0 0 P<0-01
M.I.S.§ NaAu Tumour i.v. 17 7-65 P<005
M.I.S.§ NaAu C. parvumnt Tumour i.v. 0 0-7 P<0-01
Expt 2
Tumour i.v. 3 0-25
NaAu (Day -2) Tumour i.v. 56 2-N¶ P<0-01
NaAu (Day -1) Tumour i.v. 71 34-N¶ P<0-01
NaAu (Hours -4) Tumouri.v. 31 11-N¶f P<0-01
NaAu (Day +3) Tumour i.v. 71 4-N¶ P<0-01
* 6-8 mice per group.
t Wilcoxon Rank-sum test.
t 0 7 mg C. parvum 10390 i.p. Day -1.
§ Multiple injection schedule for sodium aurothiomalate (NaAu), 3 i.p. injections a week for 8 injections
starting 2 days before tumour.
1IB x 105 fibrosarcoma cells i.v. Day 0.
¶ N = too many nodules to count. N taken to be 100 for statistical purposes.
given on Day -3 and the multiple gold The effect of gold salts on other biological
salt schedule was started on Day -4. changes caused by C. parvum
The adjuvant action of C. parvum was, C. parvum causes a wide variety of
as expected, apparent from Day 7 on physiological and cellular changes that
in both experiments. Gold salts appeared may or may not be related to its anti-
to delay all responses (Fig. 2a, b) and to tumour action. The effect of gold salt
slightly decrease the peak titres. In on some of these can be seen in Table II.
fact, in both experiments the delay was Gold salt in multiple injections i.p.
primarily due to a lack of 2-mercapto- prevented many of the sequelae of C.
ethanol sensitive (IgM) antibody in the parvum injection. Thus, the develop-
gold treated mice on Day 4. The 2- ment of splenomegaly was inhibited,
mercaptoethanol resistant (JgG) antibody particularly when treatment was started
was slightly affected but less so. The before C. parvum injection. The de-
adjuvant action of C. parvum could still creased packed cell volume, white cell and
be seen in gold treated mice but appeared nucleated bone marrow count that follow
to be slightly suppressed in those given C. parvum injection did not develop.
SRBC by the subcutaneous route. In contrast, gold salts did not restrict
The immune response to C. parvum.- the C. parvum induced increase in peri-
The antibody response to C. parvum in pheral blood monocytes. Interpretation
mice has already been described (Woodruff of the changes in peripheral white cells
et al., 1974b). Multiple injections of gold is, however, complicated by the fact
salts partially inhibit this response (peak that gold salt alone gave rise to a slight
titre log2 6-8 compared with log2 8-9; leucocytosis.
P < 0.01). Single doses of 1 mg gold on When peritoneal exudate cells were
Day -1, Day +1 or Day 4 had no examined on Day 1, 2 and 4 by the Gram
significant action, although there was a stain for the presence ofthe i.p. injected C.
suggestion that prior treatment could be parvum, the total number of cells con-
effective (P < 0-1). taining C. parvum was at all times564 W. H. McBRIDE, S. TUACH AND B. P. MARMION
TABLE II.-The Effect of Gold Salt on Biological Changes Caused by C. parvum
Spleen Packed Nucleated bone
weight blood cell PWBC Differential marrow cells
Treatment (mg) vol. % (x 106/ml) M, polys, lymph ( x 106 perfemur)
NaAuM.I.S.* C. parvumt 106±5-8$ 46-1±2-4 6-6+1-4 14, 46, 40 15
NaAu Day-1* C. parvum 184±27-0 N.D. N.D. N.D. N.D.
NaAu Day +1* C, parvum 399±37 3 N.D. N.D. N.D. N.D.
NaAu Day +4* C, parvum 350±51-5 N.D. N.D. N.D. N.D.
C. parvum 449±16-8 36-0±0-8 3-2±0-9 15, 31, 55 7
NaAu M.I.S.4 81±7-6 52-0±1-0 10-1±2-6 6, 37, 57 17
86±11-6 52-6±1-1 7-4±1-5 4, 24, 72 18
* Mice received 1 mg i.p. injections of sodium aurothiomalate either in multiple doses (M.I.S.) or as
single doses on Day -1, Day + 1 or Day +4.
t 0 7 mg C. parvum i.p. Day 0.
I1 s.e. mean. Each value represents the mean of at least 6 mice.
All measurements were performed on Day 12.
TABLE III.-The Effect of Route of Injec- by C. parvum it is important that the
tion upon Inhibition by Gold Salt of gold salt be given by the same route as
C. parvum Induced Splenomegaly the C. parvum (Table III). Histological
Treatment examination showed what appeared to
C. parvum* Goldsaltt (m)Spleeneweight be gold granules within macrophages and
iGp-ll 68 6 some of these cells were also found to
i.p. i.p. 142 40 contain C. parvum if it was given by the
i.p. 312 55 same route.
i.v. i.v. 168 37
i.v. - 319 31
i.p. i.v. 264 17
i.v. i.p. 264 38 DISCUSSION
*0-7 mg C. parvum 10390. The available evidence suggests that
t1 mg three times a week from one day prior the anti-inflammatory agent sodium auro- to injection of C. parvum.
tMeasured ten days after injection ofC. parvum. thiomalate is rapidly concentrated within
§ Students t giving 95% confidence limits for phagocytic cells where it inhibits lyso-
mean.soa enyeatvt Pesli ad 11Gold salts i.p. or i.v. do not affect spleen somal enzyme activity (Persellin and
weights compared with saline injected controls. Ziff, 1966), probably by sulphydryl bind-
ing (Ennis, Granda and Posner, 1968).
greater in the mice also given gold salt It does not appear to affect the stability
and the number of cells containing C. of the lysosomal membrane (Ennis et al.,
parvum decreased more slowly with time 1968). It has also been reported to
in the gold treated mice. This suggested suppress the cellular and fluid phases of
a slower rate of degradation. Perhaps the in vivo inflammatory response and
surprisingly, the peritoneal exudate cells the phagocytic activity of these cells
from mice receiving gold salts and C. (Vernon-Roberts, Jessop and Dore, 1973).
parvum contained almost as many cells The number of lung tumour nodules
and as high a percentage oflarge morpho- that develop in mice injected i.v. with
logically " active " macrophages as did tumour cells is in large part dependent
those receiving only C. parvum. Again, upon nonspecific immune mechanisms.
gold salt alone slightly increased the In this study we found that gold salts
number of cells and the percentage of could readily increase the number of
" active" macrophages in the peri- tumour nodules. A similar effect can be
toneum, as judged by morphological obtained with low doses of x-irradiation
criteria. (Williams and Till, 1966; Milas et al.,
It should be noted that in order to 1974) which are known to also decrease
inhibit at least the splenomegaly caused the number of tumour cells eliminatedINHIBITION OF ANTI-TUMOUR ACTION OF Cf. PAR VUM 565
over the 24 h following injection (Brown, the early nonspecific rejection or cyto-
1973). These studies are consistent with stasis ofthe tumour inoculum. However,
the view that protection against lung direct intratumour injection of C. parvum
tumour development is largely nonspecific into the subcutaneous site seems to
and probably mediated by macrophages. favour a T-cell dependent immunological
C. parvumn protects against lung tu- rejection mechanism (Scott, 1974b) and
mour nodule development (Milas and the marked inhibition of tumour growth
Mujagic, 1972; this study) and causes 2 weeks following intraperitoneal C. par-
increased elimination of tumour cells over vum may also be T-cell dependent (Scott,
the same 24 h period (Bomford and 1974a, McBride, unpublished). There is
Olivotto, 1974), suggesting that the non- some evidence that this specific response
specific rejection mechanism is stimulated. may be due to antigenic cross-reactivity
Our finding that C. parvum could, under between C. parvum and the tumour cell
the conditions of the experiment, confer surfaces.
protection even in gold treated mice In this study prior treatment with
is probably a tribute to the intense gold salts prevented intraperitoneal C.
stimulatory action of this agent and is parvum from exerting its normal anti-
paralleled by the finding that C. granu- tumour (s.c.) effect. In C. parvum treated
losum can prevent the growth of x-irra-dia- mice the development of peritoneal cells
tion enhanced lung tumour nodules (Milas that in vitro are nonspecifically cytostatic
et al., 1974). for tumour cells is also inhibited (McBride
The mechanism by which gold salts and Ghaffar, to be published). Hibbs
injected intraperitoneally enhance the (1974) has found that the in vitro cyto-
take of subcutaneous tumour requires toxic activity of BCG activated macro-
further investigation. It is postulated phages is decreased by antagonists of
that in the untreated animal there is an lysosomal enzymes. These studies sup-
influx of macrophages into the sub- port the suggestion (Scott, 1974a) that
cutaneous site shortly after injection of systemic C. parvum acts mainly by
tumour. Gold salts might interfere with activating macrophages and nonspecific
the anti-tumour activity of these cells. early elimination or cytostatis of tumour
It should be noted that gold salts do not cells, a process that can be blocked by
appear to affect the in vitro chemotaxis gold salt. Gold salts may also partially
of cells (Russell, personal communication) suppress the specific anti-tumour response
but, as will be argued later, can affect their stimulated by C. parvum. It may be
anti-tumour action. relevant that it prevents the appearance
Inhibition of the growth of sub- of serum immunoglobulin that binds to
cutaneous tumour following injection of tumour cells and that arises following
C. parvum is well documented (Woodruff injection of C. parvum (Willmott et al.,
and Dunbar, 1973; Scott, 1974a, b). 1975). This aspect requires further in-
In this situation both nonspecific and vestigation.
specific immune responses to the growing It is also possible that by inhibiting
tumour can be stimulated. Evidence for lysosomal enzymes and/or the processing
the former is that C. parvum i.p. is of C. parvum at the macrophage level,
effective in T-cell deprived mice (Wood- gold salts prevent the general stimulus
ruff and Dunbar, 1973) and that in these of C. parvum upon other cells. Thus,
and in treated intact mice peritoneal many of the numerous in vivo conse-
macrophages and spleen cells develop quences of C. parvurm inocullation were
that, in vitro, are non-specifically cyto- inhibited by gold. It is of interest
static for tumour cells (Ghaffar et al., that the B cell mitogenicity of C.
1974; Bomford and Olivotto, 1974). It parvum. is macrophage dependent,
seems likely that C. parvum i.p. stimulates that gold can inhibit the response of566 W. H. McBRIDE, S. TUACH AND B. P. MARMION
lymphocytes to phytohaemagglutinin (Ca-
hill, 1971), a process that is macrophage
dependent, and that gold can inhibit
the stimulus to in vitro tumour cell
growth given by normal peritoneal cells
(McBride and Ghaffar, to be published).
Although we did not find a very marked
inhibition of the adjuvant action of C.
parvum in this study, further investigation
may show that this is also inhibited.
We would like to thank Krystyna
Gruszecka and Helen Parry Jones for
their help and the Cancer Research
Campaign for their support.
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